HeimKRK • WSE
add
Krka dd Novo Mesto
Við síðustu lokun
660,00 zł
Dagbil
654,00 zł - 672,00 zł
Árabil
492,00 zł - 680,00 zł
Meðalmagn
91,00
V/H-hlutf.
-
A/V-hlutfall
-
Viðskiptafréttir
UKX
0,28%
0,47%
1,09%
2,26%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(EUR) | mar. 2024info | Breyting á/á |
---|---|---|
Tekjur | 486,14 m. | 6,10% |
Rekstrarkostnaður | 165,75 m. | 3,92% |
Nettótekjur | 98,88 m. | 11,08% |
Hagnaðarhlutfall | 20,34 | 4,68% |
Hagnaður á hvern hlut | — | — |
EBITDA | 137,52 m. | -5,32% |
Virkt skatthlutfall | 16,75% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(EUR) | mar. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 563,62 m. | -0,53% |
Heildareignir | 2,86 ma. | 3,42% |
Heildarskuldir | 582,22 m. | 5,25% |
Eigið fé alls | 2,28 ma. | — |
Útistandandi hlutabréf | 30,82 m. | — |
Eiginfjárgengi | 9,02 | — |
Arðsemi eigna | 10,16% | — |
Ávöxtun eigin fjár | 12,74% | — |
Peningaflæði
Breyting á handbæru fé
(EUR) | mar. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 98,88 m. | 11,08% |
Handbært fé frá rekstri | 62,26 m. | 134,32% |
Reiðufé frá fjárfestingum | 19,16 m. | 183,47% |
Reiðufé frá fjármögnun | -8,83 m. | -23,98% |
Breyting á handbæru fé | 72,59 m. | 2.503,58% |
Frjálst peningaflæði | 4,20 m. | 130,94% |
Um
Krka, d. d., Novo mesto is an international generic pharmaceutical company with headquarters in Novo Mesto, Slovenia. In 2023, Krka Group's total sales amounted to 1.806 billion euros. The net profit of the Krka Group totalled €313.7 million. Krka sells products to more than 70 countries. In Slovenia the company has production sites in Ločna and Bršljin, Krško, Šentjernej and Ljutomer; several departments are spread across various parts of Ljubljana as well. Krka also has production and distribution centers in Russia, Poland, Croatia, and Germany. At the end of 2023, Krka Group had 12,753 employees. Wikipedia
Framkvæmdastjóri
Stofnsett
23. apr. 1954
Vefsvæði
Starfsfólk
11.745